Chaga: Antioxidant Mushroom, and Kidney Caution

Whenever a new "superfood" hits the market, the name alone does half the marketing work. Chaga (Inonotus obliquus) is a dark, almost black, rough parasitic mushroom resembling burnt charcoal, that grows mainly on birch tree trunks in the cold forests of Russia, Scandinavia, Canada, and North America. On the outside, it looks like a lump of coal growing on the tree, and inside it has a golden-brown core. For centuries, it has been used in Siberian and Russian folk medicine, mainly as a hot tea, as a cure-all for everything from digestive issues to cancer.

In the last decade, chaga has become a star in the world of "functional mushrooms," alongside reishi, lion's mane, and cordyceps, and is sold as a powder, extract, or capsules under the title "Queen of Antioxidants." And this is not entirely nonsense: in vitro, chaga is one of the densest sources of melanin, betulinic acid, and antioxidant polyphenols. But there is a huge gap between "rich in antioxidants in a test tube" and "healthy for you," and here we need to be precise and even cautious. In this article, we will separate facts from hype, and explain especially why chaga requires real caution, and why we rated it yellow.

What is Chaga?

Chaga is a mushroom from the Hymenochaetaceae family, and the dark lump harvested from the tree is not a regular mushroom but a sclerotium, a dense mass of fungal cells and wood tissue that the fungus has decomposed. Here is what is important to understand about it:

• It is rich in melanin and antioxidants. Its charcoal-black color comes from a high concentration of melanin, along with polyphenols, making its extract one of the highest in laboratory antioxidant tests (like ORAC).
• It is a source of betulinic acid and triterpenes. Because it grows on birch, it absorbs and concentrates betulinic acid and betulin derivatives from the tree bark, substances being studied for activity against tumor cells in vitro.
• It contains beta-glucan polysaccharides. These are complex sugars attributed with immune-modulating activity, a common mechanism among many "functional mushrooms."
• Note: It is particularly rich in oxalates. This is not a footnote but the critical point of this article. The high oxalate concentration in chaga is a source of real kidney risk, and we will elaborate on this later.

Chaga is not a species easily grown on a farm. Most products are based on wild harvesting, raising questions of correct identification, quality, and consistency. Another essential difference: most studies have been done on concentrated extracts (usually in hot water or alcohol), not on the raw powder that an average consumer prepares as a home tea. This distinction is important because both the benefit and the risk depend heavily on the preparation method and dosage.

Connection to Health: Proposed Mechanisms

To understand why chaga generates interest, and also why the enthusiasm outpaces the evidence, it is helpful to know the mechanisms proposed by researchers. It is important to emphasize upfront: almost all of these mechanisms have been demonstrated in cells in a petri dish or in mice, not in humans.

First mechanism: antioxidant activity. Chaga extract is rich in polyphenols and melanin, which can neutralize free radicals in vitro. The theoretical logic is that reducing oxidative stress may support cell health and slow aging processes. But a high antioxidant value in a dish does not automatically translate to benefit in a living body, which has its own antioxidant systems and where the bioavailability of substances is limited.

Second mechanism: anti-inflammatory and immune-modulating activity. The beta-glucans in chaga have been studied for their ability to affect immune system cells and inflammatory mediators. In mice, chaga extracts showed a reduction in inflammatory markers. As always with immune-modulating substances, this is a double-edged sword: the same immune activity could be a problem for people with autoimmune diseases or those taking immunosuppressive drugs.

Third mechanism: effect on blood sugar. In diabetic mouse models, chaga extracts (mainly the polysaccharides) were linked to decreased blood sugar levels and improved insulin sensitivity. This is a promising finding in animals only, but it is also the basis for an important interaction warning: combining it with blood sugar-lowering medications could cause blood sugar to drop too much.

Fourth mechanism: activity against tumor cells. Betulinic acid and triterpenes in chaga have shown in vitro the ability to inhibit the proliferation of cancer cell lines and promote programmed cell death (apoptosis) in various cells. It is very important to clarify: these are cells in a dish and mice, and there is no clinical evidence that chaga treats or prevents cancer in humans. Its folk use as a "cancer remedy" is not supported by human research, and is sometimes even dangerous if it replaces proven medical treatment.

Current Evidence

Study 1: Report of Kidney Failure from Oxalates, Kikuchi et al. 2014

This is actually the strongest and most important human evidence on chaga, and ironically, it is evidence of harm, not benefit. In 2014, Kikuchi et al. published in the journal Clinical Nephrology the world's first report of oxalate nephropathy (kidney damage from oxalates) caused by chaga consumption.

The case: A 72-year-old Japanese woman, diagnosed a year earlier with liver cancer and having undergone surgery, took chaga powder at a dose of 4 to 5 teaspoons per day for about 6 months as a "cure" for cancer. Her kidney function deteriorated to the point where she required dialysis. A kidney biopsy showed extensive degeneration of the renal tubules, scarring (fibrosis) in the interstitial tissue, and oxalate crystals within the tubules and in the urine sediment. The researchers explicitly noted that chaga mushrooms contain particularly high oxalate concentrations, and determined this was the first documented case of its kind. Similar case reports of kidney failure from chaga have since been published from Korea and other reports, reinforcing the concern.

Study 2: Evidence for Benefit, Reviews of Lab and Animal Studies

When examining the positive side, the picture is clear but disappointing in terms of evidence strength. Recent scientific reviews (e.g., in Heliyon and the Journal of Ethnopharmacology) summarize dozens of studies showing antioxidant, anti-inflammatory, anti-diabetic, liver-protective, and anti-tumor activity. But almost all of these studies are in vitro (cells in a dish) or animal studies.

The bottom line repeated in almost every review is the same: the preclinical evidence is promising, but high-quality, controlled clinical trials in humans are lacking to establish any health benefit. In other words, we know what chaga does in a dish and in a mouse, but we hardly know what it does in a human, at what dose, and with what long-term safety.

Study 3: Lack of Controlled Clinical Trials in Humans

This is perhaps the most important finding for understanding the rating, and it is a finding of absence. To date, there are no large, high-quality randomized controlled trials (RCTs) that have examined chaga in humans for effects on antioxidants, immunity, blood sugar, or cancer. Institutions like Memorial Sloan Kettering Cancer Center explicitly state that the benefits are based solely on lab and animal studies, and that chaga is not a substitute for medical treatment.

The implication is simple: any specific marketing promise about a health benefit in humans goes beyond what science can currently support. Chaga is a classic case where hype and tradition run far ahead of the evidence, while at the same time there is a real and documented risk of harm. This combination—weak evidence of benefit alongside a tangible safety risk—is exactly what dictates this cautious rating.

What About Other "Functional Mushrooms"?

Chaga is not alone in this category, and it is worth seeing it in a broader context. Other functional mushrooms like reishi, lion's mane, and cordyceps also enjoy a "superfood" aura, and most have slightly more early human data than chaga, though still limited. Their common denominator is beta-glucans and purported immune-modulating activity.

But chaga has a characteristic that sets it apart negatively: its particularly high oxalate content, which is not as characteristic of the other mushrooms. Therefore, even within the internal comparison of the functional mushroom world, chaga is the one that requires the most caution. If you are still interested in this type of mushroom, mushrooms with a clearer safety profile might be a more logical starting point, always subject to personal assessment.

Should You Start Taking Chaga?

This is exactly why we rated chaga yellow, with a tendency toward caution. On one hand, there is an impressive antioxidant profile in the lab and a long tradition of use; on the other hand, human evidence for benefit is almost non-existent, and there is a real and documented safety risk. Here are the main considerations:

• Kidney risk, the most important point. Chaga is very rich in oxalates, and there is a documented medical report of oxalate nephropathy leading to dialysis after prolonged use. People with kidney disease, a history of kidney stones (oxalate stones), or poor kidney function should avoid chaga entirely. Even healthy people should avoid high doses and long-term chronic use.
• Evidence for benefit is weak. Almost everything known about chaga comes from test tubes and animals. There are no large clinical trials proving benefit in humans, and this alone justifies lowering expectations.
• Interactions with medications. Chaga is attributed with mild blood-thinning activity, so combining it with anticoagulants (like warfarin) or aspirin requires caution. Additionally, its potential effect on blood sugar could conflict with diabetes medications and cause hypoglycemia.
• Uncertain quality and identification. Since chaga is wild-harvested, there is a risk of misidentification, contamination with heavy metals that the mushroom absorbs from the environment, and significant variability between products. Without third-party testing, it is difficult to know exactly what is in the box.

Beyond the clear risk groups, it must be emphasized: pregnant or breastfeeding women should avoid it due to a lack of safety data. Those about to undergo surgery should stop taking it in advance due to the potential effect on blood clotting and sugar. And above all, chaga should not be seen as a cancer treatment or a substitute for medical care, as we saw, it was precisely such use that led to the documented kidney case. As always: the absence of a dramatic warning on the product does not mean it is safe for everyone.

What to Take Away from the Research?

1. If you have a kidney problem or stones, avoid it entirely. This is not a flexible recommendation. The high oxalate content and the documented report of kidney failure make chaga a dangerous choice for you.
2. Do not expect "antioxidant magic." A high antioxidant value in a test tube is not proven benefit in the body. If the goal is antioxidants, a diet rich in vegetables, fruits, and polyphenols is a much more established and safer path.
3. Never use chaga as a cancer treatment. There is no scientific basis for this in humans, and use that replaces proven treatment can be harmful. If diagnosed, consult only with your medical team.
4. Check for interactions with medications. If you are taking anticoagulants, aspirin, or diabetes medications, consult a doctor or pharmacist before taking chaga.
5. If you still try it, use a small dose and only for a short time. Choose a product with third-party testing for heavy metals, avoid long-term chronic use, and drink plenty of water. But remember that even then, the benefit is not guaranteed.

For those who still choose to try chaga from a verified source, you can purchase chaga on iHerb and prefer brands that publish lab tests. But with this mushroom, the safety profile is as important as the quality. To check which supplements are truly suitable for your health goals based on age and condition, and at what level of evidence they are supported, you can use our personal supplement checker that rates each supplement according to evidence quality.

The Broader Perspective

Chaga is an almost perfect example of the gap between tradition, the lab, and clinical reality. On one hand, centuries of traditional use and an impressive antioxidant profile in a dish. On the other hand, almost zero clinical evidence in humans, and a real and documented safety risk that could end in dialysis. This is exactly the profile that demands caution: not outright rejection, but certainly not enthusiasm.

The broader lesson extends beyond chaga itself. "Strong antioxidant in a test tube" is not synonymous with "healthy for you," and "natural" is not synonymous with "safe". Natural substances, when used in high doses and over time, can be harmful, and the kidney case of chaga is a sharp reminder of that. True health and longevity are built from the foundations: a balanced diet, physical activity, sleep, and control of risk factors, not from a single black powder that promises everything. And this is exactly the perspective we hold here: to rate each supplement according to what science actually shows, when it is promising, and when, as in the case of chaga, caution is primarily advised.

References:
Kikuchi Y. et al., Chaga mushroom-induced oxalate nephropathy, Clinical Nephrology, 2014;81(6):440-444 (DOI: 10.5414/CN107655)
Lee S. et al., Development of End Stage Renal Disease after Long-Term Ingestion of Chaga Mushroom: Case Report and Review of Literature, Journal of Korean Medical Science, 2020 (DOI: 10.3346/jkms.2020.35.e122)
Chaga Mushroom, Memorial Sloan Kettering Cancer Center, Integrative Medicine (evidence summary: lab and animal data only)